Photo of Bharath R Guru
   

View Scopus Profile

Bharath R Guru

MTech, PhD, PDF (Nanomedicine)

 https://orcid.org/0000-0003-2542-7740

  • Madhav Nagar, Room No. 5, Faculty rooms, Near KMC Administrative office

    576104 Manipal

    India

  • 433 Citations
  • 6 h-Index
20102018
If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Biotechnology

Teaching

External positions

Fingerprint Dive into the research topics where Bharath R Guru is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Nanoparticles Medicine & Life Sciences
Dendrimers Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Isoniazid Medicine & Life Sciences
Drug Compounding Medicine & Life Sciences
Microglia Medicine & Life Sciences
Antitubercular Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2010 2018

  • 433 Citations
  • 6 h-Index
  • 11 Article
2 Citations (Scopus)

Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain

Hakkimane, S. S., Shenoy, V. P., Gaonkar, S. L., Bairy, I. & Guru, B. R., 23-07-2018, In : International Journal of Nanomedicine. 13, p. 4303-4318 16 p.

Research output: Contribution to journal › Article

Hydrazones
Isoniazid
Rifampin
Mycobacterium tuberculosis
Nanoparticles
1 Citation (Scopus)

Biodegradable polymer nanoparticles of anti-tubercular drug: Formulation and in vitro release studies

Hakkimane, S. S. & Guru, B. R., 01-03-2017, In : Advanced Science Letters. 23, 3, p. 1718-1723 6 p.

Research output: Contribution to journal › Article

Drug Compounding
Biodegradable polymers
Tuberculosis
Nanoparticles
tuberculosis
2 Citations (Scopus)

Nano formulation analysis: Analytical method development of isoniazid and simultaneous estimation of antitubercular drugs isoniazid and rifampicin by reverse phase high pressure liquid chromatography

Hakkimane, S. S. & Guru, B. R., 01-01-2017, In : Asian Journal of Pharmaceutical and Clinical Research. 10, 5, p. 330-335 6 p.

Research output: Contribution to journal › Article

Antitubercular Agents
Isoniazid
Reverse-Phase Chromatography
Rifampin
High Pressure Liquid Chromatography
5 Citations (Scopus)

Design of aqueous two-phase systems for purification of hyaluronic acid produced by metabolically engineered Lactococcus lactis

Rajendran, V., Puvendran, K., Guru, B. R. & Jayaraman, G., 01-02-2016, In : Journal of Separation Science. 39, 4, p. 655-662 8 p.

Research output: Contribution to journal › Article

Hyaluronic acid
Hyaluronic Acid
Purification
Impurities
Molecular weight
4 Citations (Scopus)

Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index

Kirtane, A. R., Wong, H. L., Guru, B. R., Lis, L. G., Georg, G. I., Gurvich, V. J. & Panyam, J., 03-08-2015, In : Molecular Pharmaceutics. 12, 8, p. 2912-2923 12 p.

Research output: Contribution to journal › Article

Epidermal Growth Factor Receptor
Nanoparticles
Neoplasms
Pharmaceutical Preparations
Costs and Cost Analysis